Everest Medicines Limited (01952)

AuditorFromToRelease Date / Document LinksReason for Change
Ernst & Young (Hong Kong)15-Nov-24
Ernst & Young15-Nov-24
PwC (HK)25-Sept-2015-Nov-24
Historical transition (details not available in archive)
PwC15-Nov-24Could not reach a consensus on the audit fee.